PMDAがAPECの優良研修センターとして正式に承認 ｜報道発表資料｜厚生労働省
https://www.mhlw.go.jp/stf/houdou/0000153615.htmlBundle the HTML, screenshot, summaries, and metadata into one ZIP file. The first export request adds an external RFC 3161 timestamp before download.
PMDAがAPECの優良研修センターとして正式に承認 ｜報道発表資料｜厚生労働省
Open the dedicated viewer to inspect the saved page with archive metadata pinned above it.
This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.
The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.
This page announces that PMDA was formally approved as an APEC Center of Excellence for Regulatory Science in March 2017. PMDA was recognized in two fields: international joint clinical trials/GCP inspections and pharmaceutical safety monitoring. PMDA, Duke-NUS Medical School (Singapore), and Peking University (China) were approved for the international joint clinical trials field. Japan co-chairs the RHSC with the United States. PMDA will conduct training for pharmaceutical regulatory authorities in the APEC region and contribute to promoting ICH guidelines.
